4-Methoxycinnamaldehyde inhibited human respiratory syncytial virus in a human larynx carcinoma cell line

Phytomedicine

Volumn 16, Issue 9, 2009, Pages 882-886

  Wang, Kuo Chih ^a   Chang, Jung San ^b,c   Chiang, Lien Chai ^a   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

4 Methoxycinnamaldehyde; Prevention; RSV; Therapy; Viral entrance

Indexed keywords

4 METHOXYCINNAMALDEHYDE; CINNAMALDEHYDE DERIVATIVE; INTERFERON; UNCLASSIFIED DRUG;

AGASTACHE; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOMA CELL; CELL PROTECTION; CONTROLLED STUDY; HEP 2 CELL; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION;

ACROLEIN; AGASTACHE; CELL LINE, TUMOR; HUMANS; INTERFERONS; LARYNGEAL NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

AGASTACHE RUGOSA; HUMAN RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 67650554813     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.02.016     Document Type: Article

References (23)

1. Broughton S., and Greenough A. Drugs for the management of respiratory syncytial virus infection. Curr. Opin. Investig. Drugs 5 (2004) 862-865
2. Chiang L.C., Chiang W., Chang M.Y., Ng L.T., and Lin C.C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55 (2002) 53-62
3. Chonmaitree T., Roberts Jr. N.J., Douglas Jr. R.G., Hall C.B., and Simons R.L. Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses. Infect. Immun. 32 (1981) 300-303
4. De Logu A., Loy G., Pellerano M.L., Bonsignore L., and Schivo M.L. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 48 (2000) 177-185
5. Falsey A.R., and Walsh E.E. Viral pneumonia in older adults. Clin. Infect. Dis. 42 (2006) 518-524
6. Groothuis J.R., and Nishida H. Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab). Pediatr. Int. 44 (2002) 235-241
7. Guo J.Y., Huo H.R., Yang Y.X., Li C.H., Liu H.B., Zhao B.S., Li L.F., Ma Y.Y., Guo S.Y., and Jiang T.L. 2-Methoxycinnamaldehyde reduces IL-1beta-induced prostaglandin production in rat cerebral endothelial cells. Biol. Pharm. Bull. 29 (2006) 2214-2221
8. Hasegawa A., Yoshino M., Nakamura H., Ishii I., Watanabe T., Kiuchi M., Ishikawa T., Ohmori S., and Kitada M. Identification of inhibitory component in cinnamon - O-methoxycinnamaldehyde inhibits CYP1A2 and CYP2E1. Drug Metab. Pharmacokinet. 17 (2002) 229-236
9. Henderson F.W., Collier A.M., Clyde Jr. W.A., and Denny F.W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 300 (1979) 530-534
10. Henrickson K.J., Hoover S., Kehl K.S., and Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23 (2004) S11-18
11. Kim H.K., Lee H.K., Shin C.G., and Huh H. HIV integrase inhibitory activity of Agastache rugosa. Arch. Pharm. Res. 22 (1999) 520-523
12. Maggon K., and Barik S. New drugs and treatment for respiratory syncytial virus. Rev. Med. Virol. 14 (2004) 149-168
13. Metcalf R.L., and Lampman R.L. Evolution of diabroticite rootworm beetle (Chrysomelidae) receptors for Cucurbita blossom volatiles. Proc. Natl. Acad. Sci. USA. 88 (1991) 1869-1872
14. Ooi L.S., Li Y., Kam S.L., Wang H., Wong E.Y., and Ooi V.E. Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. Am. J. Chin. Med. 34 (2006) 511-522
15. Raboni S.M., Nogueira M.B., Tsuchiya L.R., Takahashi G.A., Pereira L.A., Pasquini R., and Siqueira M.M. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 76 (2003) 142-146
16. Reddy A.M., Seo J.H., Ryu S.Y., Kim Y.S., Min K.R., and Kim Y. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med. 70 (2004) 823-827
17. Sandoval I.V., and Carrasco L. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J. Virol. 71 (1997) 4679-4693
18. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
19. Shin S., and Kang C.A. Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole. Lett. Appl. Microbiol. 36 (2003) 111-115
20. Sidwell R.W., and Barnard D.L. Respiratory syncytial virus infections: recent prospects for control. Antiviral Res. 71 (2006) 379-390
21. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., and Robins R.K. Broad-spectrum antiviral activity of Virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177 (1972) 705-706
22. Sperber S.J., and Hayden F.G. Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta. J. Interferon Res. 9 (1989) 285-293
23. Walsh E.E., Falsey A.R., and Hennessey P.A. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am. J. Respir. Crit. Care Med. 160 (1999) 791-795